跳至主要内容
临床试验/CTRI/2021/02/031442
CTRI/2021/02/031442招募中2 期

Evaluating feasibility of a double-blind, randomized, placebo-controlled trial ofindividualized homeopathic medicines in tinea corporis

D N De Homoeopathic Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Patients suffering from tinea corporis (2020 ICD-10-CM diagnosis code B35.4) since last 3 months
  • 2. Age 18-65 years
  • 3. Patients of either sex
  • 4. Patient using topical agents for tinea lesions will be included after a washout period of two weeks
  • 5. Patients who are literate and capable of filling the questionnaire and providing
  • written informed consent

排除标准

  • 1. Cases with complication like lichenification and eczematisation
  • 2. Similar looking skin conditions; e.g. seborrhic dermatitis, pityriasis rosea and psoriasis
  • 3. Patients who are too sick for consultation
  • 4. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled
  • or life-threatening illness affecting quality of life or any organ failure
  • 5. Pregnant and puerperial women and lactating mothers
  • 6. Substance abuse and/or dependence
  • 7. Self-reported immune-compromised state, and
  • 8. Already undergoing homeopathic treatment for chronic disease within last 6 months.

研究者

发起方
D N De Homoeopathic Medical College and Hospital

相似试验